Physician profile
Ananda Basu
NPI 1821062647
$7,249.64
in general payments reported to CMS, 2019-2025
9 companies · $413 in 2025
The $413 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,100 · 2021: $2,678 · 2022: $800 · 2023: $50.54 · 2024: $1,208 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $893 · Food and Beverage: $767 · Travel and Lodging: $12.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $892.50 |
| Food and Beverage | $766.72 |
| Travel and Lodging | $12.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $3,570.50 | 2021-2024 | |
| Intercept Pharmaceuticals, INC. | $2,100.00 | 2020 | |
| Zealand Pharma US, INC. | $800.00 | 2022 | |
| Medtronic, INC. | $377.76 | 2024-2025 | Minimed 780g |
| Inspire Medical Systems, INC. | $130.51 | 2024 | Inspire |
| Novo Nordisk INC | $112.06 | 2024-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $70.77 | 2023-2025 | Freestyle Libre 3 |
| Madrigal Pharmaceuticals | $54.48 | 2025 | Rezdiffra |
| Beta Bionics, INC. | $33.56 | 2024 | Ilet Bionic Pancreas |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ananda Basu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.